Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma - Ugurel, Selma; Schadendorf, Dirk; Sucker, Antje; Paschen, Annette (Annals of urologic oncology, 2020)
Gesehen am 02.04.2020